Vol. 21 No. 1 (2021): June 2021

View Vol. 21 No. 1 (2021): June 2021

Published: 2021-05-28

Editorials

Can we find out if COVID-19 causes diabetes?

Philip Home

1-2
- PDF
- HTML

Reviews

A perspective piece on Diabetes Self-Management Education and Support (DSMES) programmes for under-represented groups with T2DM in the UK

Michelle Hadjiconstantinou, Lauren M Quinn, Frances Tippins, Sally Schreder, Kamlesh Khunti, Melanie J Davies

3-10
- PDF
- HTML
Identifying the need for simplification of type 2 diabetes mellitus treatment in residents of aged-care facilities: a meta-analysis and systematic review of the literature

Lowri Hughes Thomas, Philip MS Evans, Atul Kalhan

11-19
- PDF
- HTML
Pharmacotherapy for weight loss in adults with type 2 diabetes: a systematic review of randomised controlled trials

Claudia Coelho, Rachel Agius, James Crane, Barbara McGowan

20-29
- PDF
- HTML
A systematic review and meta-analysis of the impact of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiovascular outcomes in biologically healthy older adults

William D Strain, Jonathan Griffiths

30-35
- PDF
- HTML
Fear of hypoglycaemia in paediatric diabetes: a literature review

Abiramy Fernando, Vinod Patel

36-42
- PDF
- HTML
A systematic review of parents’ experiences of raising a child with type 1 diabetes

Saffron Simpson, Paul Hanna, Christina J Jones

43-58
- PDF
- HTML

Original Research

The role of remnant bone microbiological cultures in managing diabetic foot osteomyelitis

Devangi Ketankumar Madani, Mujahid Ahmad Saeed, Alok Tiwari, Miruna Delia David

59-61
- PDF
- HTML
Effect of empagliflozin on albuminuria, eGFR and serum creatinine: updated results from the ABCD nationwide empagliflozin audit

Thomas SJ Crabtree, Alex Bickerton, Jackie Elliott, Rajeev Raghavan, Dennis Barnes, Siva Sivappriyan, Suzanne Phillips, Alison Evans, Devesh Sennik, Anurita Rohilla, Ian Gallen, Robert EJ Ryder, ABCD Empagliflozin Audit Contributors -

62-66
- PDF
- HTML
A service evaluation of the impact of adoption of JBDS guidelines for the management of glucose during labour and birth in women with diabetes

Umesh Dashora, Suhail Ahmed, Irene Bossman, Ko Ko Aung, Erwin Castro, Pariasamy Sathiskumar

67-75
- PDF
- HTML
The United Kingdom’s first NHS EndoBarrier service for long-standing poorly controlled type 2 diabetes and obesity: outcomes one year after EndoBarrier removal

Robert E J Ryder, Mahi Yadagiri, Wyn Burbridge, Susan P Irwin, Hardeep Gandhi, Tahira Bashir, Rachael A Allden, Melanie Wyres, Melissa Cull, John P Bleasdale, Edward N Fogden, Mark R Anderson, Piya Sen Gupta

76-83
- PDF
- HTML

Learning from practice

HbA1c and hypoglycaemia outcomes for people with type 1 diabetes due to the introduction of a single-day structured education programme and flash glucose monitoring

Gillian Garden, David W Hunt, Karen Mackie, Beverly Tuthill, Helen Griffith, David L Russell-Jones, Roselle Herring

84-88
- PDF
- HTML
Delivering joined-up care for people with type 2 diabetes: rationale, challenges and examples

Steve Bain, Alice Rickford, Neil Black, Lesley Hamilton, Elizabeth Camfield, Mark Chamley, Anna Hodgkinson, Janaka Karalliedde

89-95
- PDF
- HTML
An audit of people admitted to hospital with diabetes and coronavirus (SARS-CoV-2): data collection methods. The Association of British Clinical Diabetologists (ABCD) Nationwide Audit

Dinesh Nagi, Robert EJ Ryder, Yue Ruan, Benjamin CT Field, Parth Narendran, Rajiv Gandhi, Sophie Harris, Kinga A Várnai, Jim Davies, Sarah H Wild, Emma G Wilmot, Kamlesh Khunti, Rustam Rea

96-99
- PDF
- HTML

Current Topics

A year in diabetic nephropathy

Jovanna Tsoutsouki, Tahseen Ahmad Chowdhury

100-109
- PDF
- HTML
Series: Cardiovascular outcome trials for diabetes drugs Semaglutide and SUSTAIN-6

Miles Fisher

110-112
- PDF
- HTML
Series: Cardiovascular outcome trials for diabetes drugs Degludec and DEVOTE

Miles Fisher

113-115
- PDF
- HTML

Case Reports

Type 1 or type 2 diabetes: has the ship already sailed?

Amy E Morrison, Sing Yee Sim, Marie-France Kong, Rob Gregory

116-119
- PDF
- HTML

Commentary

Liraglutide (Saxenda®) for the treatment of obesity: a commentary on NICE Technology Appraisal 664

Hassan Kahal, Kamrudeen Mohammed, Kathryn Lonnen, Thozhukat Sathyapalan, Chris Walton

120-122
- PDF
- HTML

Position Statements

ABCD position statement on risk stratification of adult patients with diabetes during COVID-19 pandemic

Dinesh Nagi, Emma Wilmot, Karissa Owen, Dipesh Patel, Lesley Mills, Gerry Rayman, Peter Winocour, Goher Ayman, Rohit Patel, Clare Hambling, Pratik Choudhary

123-131
- PDF
- HTML
Cardiovascular impact of new drugs (GLP-1 and gliflozins): the ABCD position statement

Ansu Basu, Dipesh Patel, Peter Winocour, Bob Ryder

132-148
- PDF
- HTML

The Rowan Hillson Insulin Safety Award

The Rowan Hillson Inpatient Safety Award 2019 for the best perioperative pathway for people with diabetes

Umesh Dashora, David Burckett-St.Laurent, Nicola Leech, Ketan Dhatariya, Mike Sampson, Erwin Castro, Rowan Hillson, Christine Jones

149-153
- PDF
- HTML

Letters to the editor

Glycaemic control does not appear to correlate with mortality from COVID-19

Eunice O Wiafe, Jagannath Gopalappa, Vijay Jayagopal

154-155
- PDF
- HTML
Re-audit of bedside glucose monitoring of inpatients on glucocorticoids: have we improved?

David Bawden, Ranu Baral, Smriti Gaur, Rebecca Rogers, Ketan Dhatariya

156-157
- PDF
- HTML
Fixed-dose combination: beware of its limitations

Neelesh Gupta, Mohammed Elkhazendar, Rajeev Gupta

157
- PDF
- HTML

ABCD News

ABCD, DTN-UK, and YDEF News

Dipesh Patel, Umesh Dashora, Rebecca Reeve, Pratik Choudhary, Tim Robbins

158-168
- PDF
- HTML

Abstracts

ABCD Conference 2020 Abstracts

ABCD Conference 2020

ONLINE ONLY
- PDF
- HTML